Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Corcept Therapeutics (CORT)

Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
SOUN
SoundHound AI, Domo, Plug Power, Corcept, and 8x8 Shares Are Falling, What You Need To Know StockStory - Wed Apr 16, 2:55PM CDT

SoundHound AI, Domo, Plug Power, Corcept, and 8x8 Shares Are Falling, What You Need To Know

CORT : 62.24 (-3.65%)
SOUN : 7.82 (+0.77%)
PLUG : 0.9003 (-2.26%)
DOMO : 6.93 (-2.81%)
EGHT : 1.5800 (unch)
Author
3 Biopharmaceutical Stocks Bucking the Sell-Off MarketBeat - Thu Apr 10, 6:00AM CDT

Three biopharma companies may appeal to investors looking for firms that have not been rocked by tariff-inspired turbulence.

CORT : 62.24 (-3.65%)
DBVT : 7.98 (+0.88%)
SLRN : 2.20 (unch)
ABBV : 172.99 (+0.76%)
ALMS : 5.00 (-1.38%)
LLY
Q4 Earnings Highs And Lows: Eli Lilly (NYSE:LLY) Vs The Rest Of The Branded Pharmaceuticals Stocks StockStory - Thu Apr 10, 4:15AM CDT

Q4 Earnings Highs And Lows: Eli Lilly (NYSE:LLY) Vs The Rest Of The Branded Pharmaceuticals Stocks

CORT : 62.24 (-3.65%)
SUPN : 30.76 (+0.16%)
LLY : 839.96 (+14.30%)
ZTS : 148.67 (+1.30%)
BMY : 49.23 (-0.26%)
OGN
Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded Pharmaceuticals Segment StockStory - Tue Apr 8, 4:07AM CDT

Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded Pharmaceuticals Segment

CORT : 62.24 (-3.65%)
OGN : 11.12 (+2.77%)
SUPN : 30.76 (+0.16%)
MRK : 78.00 (+2.01%)
ZTS : 148.67 (+1.30%)
SNY Gets FDA Nod for First Ever Hemophilia Drug in the United States
SNY Gets FDA Nod for First Ever Hemophilia Drug in the United States Zacks Investment Research - Tue Apr 1, 9:58AM CDT

Sanofi SNY and partner, Alnylam Pharmaceuticals ALNY, announced that the FDA has approved Qfitlia (fitusiran) as the first antithrombin-lowering (AT) therapy for routine prophylaxis to prevent or reduce...

BAYRY : 6.0200 (+1.86%)
CORT : 62.24 (-3.65%)
ALNY : 234.56 (+1.76%)
SNY : 50.90 (+0.67%)
CORT
Why Is Corcept (CORT) Stock Soaring Today StockStory - Mon Mar 31, 1:48PM CDT

Why Is Corcept (CORT) Stock Soaring Today

CORT : 62.24 (-3.65%)
CORT
3 Reasons to Sell CORT and 1 Stock to Buy Instead StockStory - Wed Mar 26, 4:41PM CDT

3 Reasons to Sell CORT and 1 Stock to Buy Instead

CORT : 62.24 (-3.65%)
TDG : 1,337.66 (+0.10%)
NX
3 Growth Stocks in Hot Water StockStory - Wed Mar 19, 8:03AM CDT

3 Growth Stocks in Hot Water

CORT : 62.24 (-3.65%)
NX : 16.18 (+2.28%)
SEM : 16.36 (+0.18%)
SEMR
1 Small-Cap Stock on Our Buy List and 2 to Avoid StockStory - Fri Mar 14, 8:03AM CDT

1 Small-Cap Stock on Our Buy List and 2 to Avoid

CORT : 62.24 (-3.65%)
SEMR : 8.97 (+0.90%)
NYT : 49.27 (+0.96%)
Corcept Shares Rise More Than 55% in 6 Months: Here's Why
Corcept Shares Rise More Than 55% in 6 Months: Here's Why Zacks Investment Research - Fri Mar 7, 11:08AM CST

Shares of Corcept Therapeutics Incorporated CORT have rallied 56.4% in the past six months against the industry’s decline of 10.5%.The company’s sole-marketed drug, Korlym (mifepristone), which is...

CORT : 62.24 (-3.65%)
JAZZ : 102.78 (+1.21%)
ANIP : 69.21 (+0.01%)
ORGO : 4.22 (-0.71%)

Barchart Exclusives

1 ‘Defensive’ Cathie Wood Stock to Buy While It’s at a ‘Great Entry Point’ Barchart - 20 minutes ago
One Wall Street analyst is backing up Cathie Wood’s view that DraftKings is a stock to buy in 2025. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot